Evotec Extends Takeda Pact to Gene Therapy

Takeda Thus Becomes Evotec’s First Gene Therapy Discovery Partner

Evotec is building a gene therapy R&D center manned by ex-Takeda scientists and has already landed a multi-year drug discovery pact for it with their former Japanese employer.

Sign_Gene_Therapy
Deal comes as Evotec builds its first gene therapy R&D center, using ex-Takeda workers • Source: Shutterstock

Evotec SE is expanding into the field of gene therapy by building an R&D center in Austria using scientists previously employed by Takeda, whose first project will be a long-term research and discovery project with their former Japanese employer, exploring oncology, rare diseases, neuroscience and gastroenterology.

The entry by the German discovery alliance and development partnership group into gene therapy further expands its capabilities beyond small...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip